Press Releases
Toyota City, Japan, Jun 3, 2024 - (JCN Newswire) - - TOYOTA GAZOO Racing World Rally Team and Sebastien Ogier looked set to secure a third consecutive victory together at Rally Italia Sardegna before late drama in the final few kilometres of the event meant they missed out by the narrowest of margins.
Car 17 (Sebastien Ogier, Vincent Landais)
Ogier was involved in a close battle for the lead for most of the event, and while a strong Saturday afternoon enabled him to lead... (continue reading...)
— AMD Ryzen™ AI 300 Series Processors Unlock Transformational AI Experiences for Windows Copilot+ PCs —
— AMD Ryzen™ 9000 Series Processors Set New Standards in Efficiency, Performance, and Content Creation —
TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- Today, during Computex 2024, AMD (NASDAQ: AMD) announced a groundbreaking series of next-generation architecture and products aimed at ushering in a new era of AI experiences. AMD is introducing new... (continue reading...)
— Updated AMD Instinct accelerator roadmap brings annual cadence of leadership AI performance and memory capabilities —
— New AMD Instinct MI325X accelerator expected to be available in Q4 2024 with up to 288GB of HBM3E memory; new AMD Instinct MI350 series accelerators based on AMD CDNA 4 architecture expected to be available in 2025 with 35x generational increase in AI inference performance —
TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- At... (continue reading...)
— Expanded AMD Instinct accelerator roadmap brings annual cadence of leadership AI accelerators; next generation AMD EPYC processors to extend data center CPU leadership —
— New AMD Ryzen AI 300 Series laptop and AMD Ryzen 9000 Series desktop processors deliver leading performance for Copilot+ PCs, gaming, content creation and productivity —
TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- Today at the Computex 2024 opening keynote, AMD (NASDAQ: AMD)... (continue reading...)
NANJING, China, June 2, 2024 /PRNewswire/ -- The annual meeting of the American Society of Clinical Oncology (ASCO) commenced on May 31st, Showcasing groundbreaking cancer research from around the world. According to official information, over 7,000 abstracts were submitted this year. After rigorous evaluation by Scientific Program Committee and ASCO Leadership, LBL-024, a bispecific antibody independently developed by Leads Biolabs with global intellectual property... (continue reading...)
More Press Releases
View Older Stories-
Appointment of Director to Woodside Board
-
NOTICE OF THE TWENTY-FIFTH ANNUAL GENERAL MEETING OF SHAREHOLDERS
-
Fujitsu Japan and Juntendo University launch joint research for disaster-resilient, digital medical system
-
2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner
-
Flash News: OKX Launches 100% Fee Rebate Campaign
-
Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in Japan
-
LaVie Care Centers Takes Strategic Actions to Position the Company for Long-Term Success Amidst Challenging Skilled Nursing Operating Environment
-
Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatme
-
Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer a
-
SATO Technologies Corp. Reports Limited Incident at the Building Hosting Data Center One
-
China Medical University Hospital (CMUH, Taiwan) Signs MOU with Malaysian International Medical University
-
Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis
-
TECNO exhibits its diverse smartphone and AIoT ecosystem with futuristic AR and AI products at COMPUTEX Taipei 2024, with the concept "Smart of Creation"
-
MSI Unveils New AI and Computing Platforms with 4th Gen AMD EPYC™ Processors at Computex 2024
-
Nissan Demonstrates Autonomous-Drive Mobility Services Progress on Public Roads
-
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial
-
WEBTOON Entertainment Announces Public Filing of Registration Statement for Proposed Initial Public Offering
-
Mesoblast Corporate Presentation at Investor Conference
-
HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
-
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Other World Computing Introduces Intel Thunderbolt Share for the Thunderbolt Go Dock
-
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
-
Fast Guard Service Shares Their Experience with Local Business Owner as the Best Security Guard Company in California
-
One in Five European Companies Are Facing Strong Pressure to Transform to Stay Viable
-
New Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse
-
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
-
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
-
FrogData Unveils Major AI Factory Upgrade to Revolutionize Automotive Retail Operations
-
izmostock Unveils Revolutionary Image Solution for Leasing Industry, Driving Unparalleled ROI and User Engagement
-
Summer Ready with Ulike Air 10: Your Smoothness Companion
-
When Solar PV Meets Blockchain: Pse.USDT Leading the Green Energy Revolution
-
TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial
-
GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
-
Miami Beach Inspires this Summer with Film, Fashion and Music Experiences
-
CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated
-
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting
-
Rokid AR Lite Crowdfunding Surpasses $600,000 with One Day Left for Early Bird Price of $479
-
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
-
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
-
Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
-
Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
-
Discovery of World War II fighter plane sets path for first U.S.-Papua New Guinea Sister City
-
Linker Vision to Accelerate Vision AI Adoption Across Enterprise Applications with Large Vision Models, in Collaboration with NVIDIA
-
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
-
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
-
ConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA
-
Boomco (BOOM) Is Now Available for Trading on LBank Exchange
-
ASRock Rack Launches New Servers Supporting the NVIDIA Blackwell Architecture at COMPUTEX 2024
-
Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
-
MEDSIR's PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer